MIH promotes the anti-tumor effect of RT via Bax-mediated cell death, enhances the immunity of cells undergoing RT, and suppresses the increase in matrix metalloproteinase-9 (MMP-9) expression induced by RT. Here, MMP9 is linked to neoplasm.